Cyanine 5.5 Conjugated Nanobubbles as a Tumor Selective Contrast Agent for Dual Ultrasound-Fluorescence Imaging in a Mouse Model

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Mai, Liyi ^a   Yao, Anna ^a   Li, Jing ^a   Wei, Qiong ^a   Yuchi, Ming ^a   He, Xiaoling ^b   Ding, Mingyue ^a   Zhou, Qibing ^a,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Hospital of China University of Geosciences   (China)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CHITOSAN; CONTRAST MEDIUM; CYANINE DYE 5; CYANINE DYE 5.5 NANOBUBBLE CONJUGATE; NANOBUBBLE; NANOMATERIAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER; CANCER CELL; CANCER LOCALIZATION; CELL STIMULATION; CONTROLLED STUDY; CROSS LINKING; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG SELECTIVITY; DRUG SYNTHESIS; DUAL ULTRASOUND FLUORESCENCE IMAGING; FEMALE; FLUORESCENCE IMAGING; IN VITRO STUDY; IN VIVO STUDY; LIPID ANALYSIS; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; SIGNAL TRANSDUCTION; TUMOR DIAGNOSIS;

ANIMALS; ASCORBIC ACID; CARBOCYANINES; CELL LINE, TUMOR; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; MICE; MICE, INBRED BALB C; MICROBUBBLES; NEOPLASMS;

MUS;

EID: 84876304987     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061224     Document Type: Article

References (37)

1. Ferrara KW, Borden MA, Zhang H, (2009) Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Acc Chem Res 42: 881-892.
2. Lindner JR, (2004) Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 3: 527-532.
3. Schutt EG, Klein DH, Mattrey RM, Riess JG, (2003) Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew Chem Int Ed Engl 42: 3218-3235.
4. Pysz MA, Foygel K, Panje CM, Needles A, Tian L, et al. (2011) Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging. Invest Radiol 46: 187-195.
5. Galiè M, D'Onofrio M, Montani M, Amici A, Calderan L, et al. (2005) Tumor vessel compression hinders perfusion of ultrasonographic contrast agents. Neoplasia 7: 528-536.
6. Eichhorn ME, Klotz LV, Luedemann S, Strieth S, Kleespies A, et al. (2010) Vascular targeting tumor therapy: non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculation. Cancer Biol Ther 9: 794-802.
7. Xing Z, Wang J, Ke H, Zhao B, Yue X, et al. (2010) The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging. Nanotechnology 21: 145607.
8. Krupka TM, Solorio L, Wilson RE, Wu H, Azar N, et al. (2010) Formulation and characterization of echogenic lipid-Pluronic nanobubbles. Mol Pharm 7: 49-59.
9. Wang Y, Li X, Zhou Y, Huang P, Xu Y, (2010) Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery. Int J Pharm 384: 148-153.
10. Marxer EE, Brüssler J, Becker A, Schümmelfeder J, Schubert R, et al. (2011) Development and characterization of new nanoscaled ultrasound active lipid dispersions as contrast agents. Eur J Pharm Biopharm 77: 430-437.
11. Yin T, Wang P, Zheng R, Zheng B, Cheng D, et al. (2012) Nanobubbles for enhanced ultrasound imaging of tumors. Int J Nanomedicine 7: 895-904.
12. Hobbs S, Monskey W, Yuan F, Roberts G, Griffith L, et al. (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95: 4607-4612.
13. Weller GE, Wong MK, Modzelewski RA, Lu E, Klibanov AL, et al. (2005) Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 65: 533-539.
14. Stieger SM, Dayton PA, Borden MA, Caskey CF, Griffey SM, et al. (2008) Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging 3: 9-18.
15. Jun HY, Park SH, Kim HS, Yoon KH, (2010) Long residence time of ultrasound microbubbles targeted to integrin in murine tumor model. Acad Radiol 17: 54-60.
16. Warram JM, Sorace AG, Saini R, Umphrey HR, Zinn KR, et al. (2011) A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature. J Ultrasound Med 30: 921-931.
17. Deshpande N, Ren Y, Foygel K, Rosenberg J, Willmann JK, (2011) Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging. Radiology 258: 804-811.
18. Kwon IK, Lee SC, Han B, Park K, (2012) Analysis on the current status of targeted drug delivery to tumors. J Control Release 154: 104-118.
19. Xu RX, (2011) Multifunctional microbubbles and nanobubbles for photoacoustic imaging. Contrast Media Mol Imaging 6: 401-411.
20. Kim C, Qin R, Xu JS, Wang LV, Xu R, (2010) Multifunctional microbubbles and nanobubbles for photoacoustic and ultrasound imaging. J Biomed Opt 15: 010510.
21. Nguyen QT, Olson ES, Aguilera TA, Jiang T, Scadeng M, et al. (2010) Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci USA 107: 4317-4322.
22. Gray DC, Kim EM, Cotero VE, Bajaj A, Staudinger VP, et al. (2012) Dual-mode laparoscopic fluorescence image-guided surgery using a single camera. Biomed Opt Express 3: 1880-1890.
23. Tichauer KM, Samkoe KS, Sexton KJ, Gunn JR, Hasan T, et al. (2012) Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging. J Biomed Opt 17: 066001.
24. Ke H, Xing Z, Zhao B, Wang J, Liu J, et al. (2009) Quantum-dot-modified microbubbles with bi-mode imaging capabilities. Nanotechnology 20: 425105.
25. Liu Z, Koczera P, Doleschel D, Kiessling F, Gätjens J, (2012) Versatile synthetic strategies for PBCA-based hybrid fluorescent microbubbles and their potential theranostic applications to cell labelling and imaging. Chem Commun 48: 5142-5144.
26. Xu JS, Huang J, Qin R, Hinkle GH, Povoski SP, et al. (2010) Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging. Biomaterials 31: 1716-1722.
27. John R, Nguyen FT, Kolbeck KJ, Chaney EJ, Marjanovic M, et al. (2012) Targeted multifunctional multimodal protein-shell microspheres as cancer imaging contrast agents. Mol Imaging Biol 14: 17-24.
28. Xing W, Zhigang W, Bing H, Haitao R, Pan L, et al. (2010) Targeting an ultrasound contrast agent to folate receptors on ovarian cancer cells: feasibility research for ultrasonic molecular imaging of tumor cells. J Ultrasound Med 29: 609-614.
29. Pan TL, Wang PW, Al-Suwayeh SA, Huang YJ, Fang JY, (2012) Toxicological effects of cationic nanobubbles on the liver and kidneys: Biomarkers for predicting the risk. Food Chem Toxicol 50: 3892-3901.
30. Hwang TL, Fang CL, Al-Suwayeh SA, Yang LJ, Fang JY, (2011) Activated human neutrophil response to perfluorocarbon nanobubbles: oxygen-dependent and-independent cytotoxic responses. Toxicol Lett 203: 172-180.
31. Wei Q, Zhang D, Yao A, Mai L, Zhang Z, et al. (2012) Design, synthesis, and in vitro and in vivo biological studies of a 3′-deoxythymidine conjugate that potentially kills cancer cells selectively. PLoS ONE 7(12): e52199 doi:10.1371/journal.pone.0052199.
32. Sennoga CA, Yeh JS, Alter J, Stride E, Nihoyannopoulos P, et al. (2012) Evaluation of methods for sizing and counting of ultrasound contrast agents. Ultrasound Med Biol 38: 834-845.
33. Qin S, Caskey CF, Ferrara KW, (2009) Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol 54: R27-57.
34. Sirsi S, Feshitan J, Kwan J, Homma S, Borden M, (2010) Effect of microbubble size on fundamental mode high frequency ultrasound imaging in mice. Ultrasound Med Biol 36: 935-948.
35. Goertz DE, de Jong N, van der Steen AF, (2007) Attenuation and size distribution measurements of Definity and manipulated Definity populations. Ultrasound Med Biol 33: 1376-1388.
36. Wong KT, Ahuja AT, (2005) Ultrasound of thyroid cancer. Cancer Imaging 5: 167-176.
37. Wang Y, Li L, Wang YX, Feng XL, Zhao F, et al. (2012) Ultrasound findings of papillary thyroid microcarcinoma: a review of 113 consecutive cases with histopathologic correlation. Ultrasound Med Biol 38: 1681-1688.